![]() |
|
|
-ERYTHROIDINE, MYANESIN OR EVIPAL
1 The Department of Pediatrics and The Department of Surgery, Division of Orthopedics, The University of Rochester School of Medicine and Dentistry, Rochester 7, New York
d-Tubocurarine and
-erythroidine administered jointly show potentiation in effective and lethal doses. The margin of safety of the mixture of the drugs is smaller than that of d-tubocurarine administered alone. The combined administration of d-tubocurarine and myanesin showed slight potentiation in lethal doses and incomplete additive action in effective doses. d-Tubocurarine and evipal showed incomplete additive action in both effective and lethal doses. The significance of the findings is discussed.